Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02432326
Title A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Medicine Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Indiana University Simon Cancer Center Indianapolis Indiana 46202 United States Details
Weill Cornell Medical College New York New York 10065 United States Details
Texas Oncology - Austin Midtown Austin Texas 76104 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Texas Oncology - Fort Worth 12th Ave Fort Worth Texas 76104 United States Details
Texas Oncology, P.A. San Antonio Texas 78217 United States Details
Texas Oncology, P.A. San Antonio Texas 78229 United States Details
Texas Oncology - Tyler Tyler Texas 75702 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
Northwest Cancer Specialists, PC Vancouver Washington 98684 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field